Test-Retest Reliability And Validation For End-Tidal Carbon Dioxide Measurement (PetCO2) During Rest And Low-Loaded Steady State Work Using A Portable Capnograph.
Measurement Of End-Tidal Carbon Dioxide Partial Pressure (PetCO2) Using A Portable Capnograph During Rest and Low-Loaded Steady State Work On An Ergometer: Test Of Reproducibility and Validation Against Standard Of Care Measurement During a Cardio Pulmonary Exercise Test.
1 other identifier
observational
20
1 country
1
Brief Summary
The goal of this observational study is to investigate exhaled carbon dioxide measuring during rest and low-loaded work using a portable device (capnograph) and standard of care apparatus during a cardiopulmonary exercise test (CPET) in healthy volunteers. The study aims to answer: How reliable is exhaled end-tidal carbon dioxide measurement for an individual over time using both standard of care apparatus and a portable device during an ergometer test? Do the measurements correlate between the portable device and standard of care apparatus? How do changes in breathing instructions and placement of sampling cannula affect the measurements from the portable device (capnograph)? How is the reliability over time of other well established values from a cardio pulmonary exercise test? Participants will be asked to perform a modified cardiopulmonary exercise test on an ergometer twice, separated in time (1-4 weeks). Measurements are sampled alternating standard of care apparatus and a portable capnograph at rest and during low-loaded work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2025
CompletedFirst Submitted
Initial submission to the registry
December 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJanuary 8, 2026
January 1, 2026
8 months
December 17, 2025
January 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reliability of PetCO2 sampling repeated over time.
Intra-class correlation coefficient and covariance for repeated measurements with the handheld capnopragh and ergospiromtry at the same workload over time. What is the reliability of PetCO₂ measurement in the same individual, using a handheld PetCO₂ monitor with mask/nasal cannula compared to a closed respiratory gas analysis system (ergospirometry), during repeated measurements on two different days, at rest and at various levels of exertion during a cycle ergometer test?
Up to 4 weeks
Secondary Outcomes (3)
Correlation of PetCO2 measurements between standard of care ergospirometry and handheld PetCO2 monitor
Up to 4 weeks
Correlation measured as agreement for different sampling methods on the handheld capnograph.
Up to 4 weeks
Intraclass correlation coefficient and covariance for other established ergospirometric variables (VO2peak, VE/VCO2slope)
Up to 4 weeks
Study Arms (1)
Cohort 1 - Healthy volunteers
Cohort 1 consists of 20 study participants eligable with the inclusion and exclusion criteria.
Eligibility Criteria
Healthy volunteer research participants recruited through advertisements at the research group's workplaces.
You may qualify if:
- Adults aged between 18 and 70 years.
- Proficient in spoken and written Swedish.
- Capable of cycling on an exercise bicycle.
You may not qualify if:
- Current symptoms of upper respiratory tract infection or fever within the past 5 days
- Obesity (BMI \> 30 kg/m²)
- Known respiratory pattern disorders/hyperventilation syndrome
- More than mild asthma or other pulmonary diseases
- Cardiovascular disease (except for hypertension with or without treatment, mild heart valve disease at most, previous pericarditis \> 12 months prior)
- Known pregnancy
- Presence of exertion-related symptoms such as chest pain, dizziness, syncope, arrhythmia, or abnormal shortness of breath
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Region Östergötland
Linköping, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Kristofer Hedman, PhD. Associate professor
Linkoeping University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Associate Professor
Study Record Dates
First Submitted
December 17, 2025
First Posted
January 8, 2026
Study Start
June 6, 2025
Primary Completion
January 19, 2026
Study Completion
February 1, 2026
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share